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Abstract- This paper discusses the use of machine learning techniques for the 
classification of medical data, specifically for guiding disease modifying therapies 
for Sickle Cell. Extensive research has indicated that machine learning 
approaches generate significant improvements when used for the pre-processing 
of medical time-series data signals and have assisted in obtaining high accuracy 
in the classification of medical data. The aim of this paper is to present findings 
for several classes of learning algorithm for medically related problems. The 
initial case study addressed in this paper involves classifying the dosage of 
medication required for the treatment of patients with Sickle Cell Disease. We 
use different machine learning architectures in order to investigate the accuracy 
and performance within the case study. The main purpose of applying 
classification approach is to enable healthcare organisations to provide accurate 
amount of medication. The results obtained from a range of models during our 
experiments have shown that of the proposed models, recurrent networks 
produced inferior results in comparison  to conventional feedforward neural 
networks and the Random Forest model. Results have also indicated that for the 
recurrent network models tested, the Jordan architecture was found to yield 
significantly better outcomes over the range of performance measures 
considered. For our dataset, it was found that the Random Forest Classifier 
produced the highest levels of performance overall.  
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 1. Introduction  
Sickle cell disease (SCD) is a common serious genetic disease, which has a 
severe impact on the patient’s quality of life and life expectancy due to red blood 
cell (RBCs) abnormality. SCD is phenotypically complex, with various medical 
outcomes ranging from early childhood mortality to a nearly unrecognised 
condition [1]. The main reason for the disease within affected populations lies 
with a group of ancestral disorders that have resulted in a  protein mutation 
inside the RBC called haemoglobin. According to the World health Organisation 
(WHO), 7 million new born babies each year suffer either from the congenital anomaly or 
from an inherited disease [2]. Furthermore, 5% of the population around the globe 
carries trait genes for the haemoglobin disorder, primarily, thalassemia and sickle cell 
disease [3]. in S-beta thalassemia, the patient inherits one gene of sickle cell and beta 
thalassemia can be inherited from anaemia.  
SCD affects more than 1 million individuals in USA and there are over 75,000 
hospitalisations costing approximately £300 million per year for treatment of SCD 
complications [4]. According to a National Health Services (NHS) investigation 
report, there are 250,000 people with sickle cell disease in the United Kingdom 
alone [5]. Moreover, the estimated cost in 2013 to admit patients to hospital 
reached more than £ 23.8 million per annum [6].  
Thalassaemia is considered to be one of the most common of the inherited blood 
disorders [7]. This kind of disease affects the vast majority of patients suffering 
from genetic blood disorders, where the haemoglobin is measured as abnormal 
behaviour in the blood. The abnormality in this case refers to red blood cells, 
which are unable to function correctly, a condition that leads to anaemia. In this 
context, significantly abnormal haemoglobin production will lead to a decrease in 
the total amount of oxygen-carrying capacity in the blood [7]. Moreover, the 
disease can cause a number of complications, including heart failure, restricted 
growth, liver disease, organ damage and death. 
In addition to SCD, further examples of inherited diseases can potentially benefit 
from this research direction. For example, Tay-Sachs disease is another disease 
that belongs to the class of autosomal recessive genetic disorders, which in this 
case is known to cause progressive deterioration of the nervous system [8]. It is 
usually caused by the absence of an important enzyme, which is called 
hexosaminidase-A (Hex-A). Tay-Sachs disease can be easily inherited by 
children with a parent who carriers a HEXA mutation. In this case, the child will 
have a 25% chance of possessing the condition when both parents are carriers 
[9]. This disease is considered very rare in the general population around the 
world. Early symptoms often begin to appear when a baby is six months old. The 
most noticeable symptoms are red dots appearing close to the baby’s eyes. The 
vast majority of children with the Tay-Sachs disease condition die in the first 
decade of their life. This type of disease occurs due to the accumulation of a 
harmful a fatty substance called GM2 ganglioside within the brain’s nerve cells, 
progressively impairing their function and eventually causing them to die 
completely. 
In the case of SCD, recent research has shown the beneficial effects of a drug 
called hydroxyurea/hydroxycarbamide in modifying the disease phenotype [10]. 
The clinical management of this disease modifying therapy is difficult and time 
consuming for clinical staff. In order to address the significant medical variability 
presented by such a crisis, healthcare professionals must improve adherence to 
therapy, which is frequently poor and subsequently results in elevated risks and 
less benefits to patients.  
The development of medical information systems has played an important role in 
medical societies. The aim of these developments is to improve the utilisation of 
technology in medical applications [11]. Expert systems and various Artificial 
Intelligence methods and techniques have been used and developed to improve 
decision support tools for medical purposes. Machine Learning models (ML) is 
considered to be a powerful technique in the field of scientific research that 
enables computers to learn from data [12]. There are a number of machine 
learning technique for classification include the Artificial Neural Network, the 
Random Forest model, and the Support Vector Machine. In this paper, the 
application of machine learning approaches for the problem of SCD medication 
dose management is considered. 
The reminder of this paper is organized as follows. Section 2 will illustrate the 
related work, while section 3 will discuss the classification of medical data, 
including recurrent neural network architectures used for classification. The 
methodology will then be introduced in Section 4, followed by the presentation of 
our results in section 5. Finally, in Section 6 we discuss our conclusions and 
future works.  
2. Related Work 
In recent years, healthcare organisations worldwide have faced many problems 
in meeting the demands of enhanced medical sectors [13]. The main motivation 
for researchers is to produce a new system for that could provide assistance for 
health organisation to deal with their patients.  There are a number of research 
projects developed for healthcare environments based on machine learning 
approach  [14]. Several solutions have been proposed to provide support to 
physicians and medical professionals. Allayous et. al. [15] demonstrated a new 
technique based on machine learning algorithms for quantifying the high risk of 
an acute splenic sequestration crisis, which is considered a serious symptom of 
(SCD). In their research, the main aim is to learn how to predict the level of 
severity depending on the training dataset. 
The dataset was gathered from “Centre Caribéen de ladrépanocytose” during 10 
years for 42 children defined by 15 features. There are a numbers of machine 
learning methods used in their research that have the ability to evaluate the risk 
of acute splenic sequestration crisis in terms of classifying patient between sever 
and mild symptoms. The Area under Curve (AUC) and the Characteristics 
Receiver Operating Curve (ROC) were used to measure the accuracy of 
datasets. The highest numbers of accuracy were achieved through the use of 
Adaboost algorithm with 92%, while the Ranktree algorithm achieved 90%, thus 
offering a better models of diagnostic method. In [16], data mining methods 
utilising WEKA tools for SCD are proposed. The research has used two 
classification methods comprising decision trees (J48) and Random forest in 
order to make a comparison between them for classifying specific blood groups. 
The outcome of the study indicated that the Random forest algorithm achieved 
better accuracy in comparison to J48, in terms of classifying specific blood 
groups for individuals affected by SCD. Our extensive researches indicated that 
there are no studies that have been applied for classifying SCD datasets for the 
provision of accurate medication dosage predictions. Currently, all hospitals and 
healthcare sectors are using manual approaches that depend completely on 
medical consultants, which can be slow to analyse, time consuming and 
stressful. However, this study provides a system that shifts from manual input to 
automated input approaches that can offer better outcomes with reduced error 
rates. 
3. Classification 
The importance of classification techniques in the medical community, especially 
for diagnosis purposes, has gradually increased [17, 18]. The key reason for 
improving medical diagnosis is to enhance the humans ability to find better 
treatments, and to help with the prognoses of diseases to make the diagnoses 
more efficient [19], even with rare conditions [20]. The aim of the classifier is to 
learn how to extract useful information from the labelled data in order to classify 
unlabelled data. Various methods have been employed for the classification task 
[21]. They are categorised into two groups: linear and nonlinear classifiers. 
Linear classifiers are represented as a linear function (gሻ of input features x as 
illustrated in Equation (1) [22].  gሺxሻ = ݓTx + �                               (1) 
Where w is a set of weighted values, b is a bias, and T refer to matrices 
transpose. For two classes, problem c1 and c2, the input vector x is assigned to 
class c1 if g(x)>=0 and to class c2, otherwise. The decision boundary between 
class c1 and c2 is simply linear. In the previous studies, several traditional linear 
classifiers were designed and applied to perform classification in different areas 
such as Linear Discriminant Analysis. 
Nonlinear classifiers involve finding the class of a feature vector x using a 
nonlinear mapping function (f), where f is learnt from a training set T, from which 
the model builds the mapping in order to predict the correct class of the new 
data. Popular nonlinear classifier is the Artificial Neural Network (ANN) model. As 
a classifier, ANN has a number of output units, one for each class [23]. Nonlinear 
neural networks are able to create nonlinear decision boundaries between 
dissimilar classes using non-parametric approach [24]. Zhang [25] asserted that 
neural networks have the power to determine the posterior probabilities, which 
can be used as the basis for establishing the classification rule. 
In this study, we consider the use of several classes of model for data 
classification, Random Forest, Support Vector Machines, and comprising ANN. 
Additionally, we trial a subclass of ANNs known as Recurrent Neural Networks, 
which offer greater representational capacity (and conversely increased 
complexity) in comparison to feedforward ANNs.  
The knowledge representation encoded within ANN models is manifested in the 
form of directed connection weights, which collectively form the network’s 
“program”. In order to perform useful tasks, an appropriate configuration of 
weights must first be found through the use of a learning algorithm. Typically, 
during this learning procedure, the space of network weights is searched using 
an optimisation algorithm in search of solution that minimises an error defined 
according to an objective function of interest. Such an objective function is 
carefully chosen to facilitate generalisation. The dimensions of variation that 
contribute to the success of a neural network include the network connectivity 
pattern (architecture), the activation functions, determination of appropriate 
weights, and the training data presented to the network during learning. The 
computation at a single node of an ANN comprises a weighted sum of its inputs, 
in turn processed according to an activation function. Such a computation is 
demonstrated in Equation 2, where yj is the output from the jth unit in layer y, wji 
represents the weight of the ith input, xi represents the value of the ith input, and � represents the activation function. 
ݕ௝ =  � (∑ ݓ௝௜ݔ௜௠௜=଴ ) 
ANN achievements have covered different types of medical applications [26]. 
The growth of medical information has played a significant role in healthcare 
organisations [27]. The target of these improvements is to develop the usage of 
technology in medical applications [28]. Various types of Artificial Intelligence (AI) 
techniques and expert systems have been applied in order to improve decision 
( 2 ) 
support tools for health purposes. In this research, we propose to use an 
advanced neural network algorithm for medical data classification based on 
machine learning for the purpose of utilising intelligent techniques for analysing 
the huge amount of SCD datasets. The proposed research aims to use machine 
learning to compare various algorithms and ensemble models within the medical 
data context. The main reason for using machine learning algorithms (neural 
networks) is to extract the information from medical datasets automatically, 
through the use of computational and statistical techniques. There are a number 
of machine learning methods that attempt to reduce the requirement for 
humankind intuition in terms of analysing of health datasets, whereas others 
attempt to construct a collaborative approach between machine and human. 
3.1. Random Forest and Support vector Machines 
Random Forest model is an approach to machine learning that comprises 
principally the ensembling of weaker decision tree learners to constitute a strong 
overall classifier. The technique can therefore be identified as a meta-learning 
approach to problem solving. The Random Forest model is widely used in the 
medical domain for the development of classifiers [27]. The notion of random 
forest was first introduced by Tin Kam Ho in [29, 30] and subsequently 
developed into the popular form known today by Brieman in [31]. The procedure 
used in the origination of Random Forest classifiers principally comprises 
decision tree and feature bagging, resulting in a population of individual decision 
trees that are trained independently to one another and therefore remain 
uncorrelated [32]. Classification results are subsequently obtained through 
averaging the results produced by all members of the forest, allowing the 
collective knowledge of the tree learners to be operationalised to form a single 
final decision. 
Support Vector Machines (SVM) are a class of model that minimise the structural 
risk of misclassification during training, otherwise known as maximum margin 
classification, in contrast to empirical risk minimisation as is typical in models 
such as ANNs. The general idea of SVM was developed into the most widely 
used form (soft margin classification) by Vapnik and Cortes in [33], the technique 
itself originating from the ideas inherent of Statistical Learning Theory [34]. SVM 
has become an important classification approach within the medical domain in a 
broad range of applications and research [35]. The principle mechanism of SVM 
model is the use of a hyperplane, which acts as a discriminative boundary 
between classes of data points, where such a hyperplane is found through 
maximum margin optimisation during the training procedure. The addition of a 
kernel to the SVM allows such a separation to be optimised within a feature 
space of higher dimension than that of the original problem representation, 
thereby allowing non-linear boundaries to be addressed. 
3.2. Recurrent Neural Networks for Classification 
In the last couple of years, various medical applications based on RNN have 
been developed [36-38]. One of the most prominent applications of RNN is 
pattern recognition, such as automated diagnostic systems [39]. RNN can utilize 
nonlinear decision boundaries and process memory of the state, which is crucial 
for the classification tasks [26, 40, 41].  A number of studies have confirmed that 
RNN has the ability to discover linear and nonlinear relations in the medical data 
[42]. However, previous studies have undertaken the classification of sequence 
oriented data, for which the dependencies between elements of data are 
exploited for learning. In this work, we intend to explore the use of RNNs for 
pattern recognition tasks, where data elements are assumed to be independently 
drawn.  
In addition, it has been shown that RNNs have the ability to provide an insight 
into the features used to represent biological signals [43]. Therefore, the 
employment of a dynamic tool to deal with time-series data classification is highly 
recommended [44]. This type of neural network has a memory that is capable of 
storing information from past behaviours [45]. One of the most important 
applications of RNN is to model or identify temporal patterns. Chung et al. [46] 
provide a relevant commentary of this aspect, explaining that "recurrent (artificial) 
neural network models are able to exhibit rich temporal dynamics, thus time 
becomes an essential factor in their operation". Different studies have indicated 
that RNN can be applied to non-linear decision boundaries [26]. In addition, the 
main advantages of recurrent neural networks is their ability to deal with static 
and dynamical behaviours [47, 48].  One of their powerful capabilities is finite 
state machine approximation, which makes recurrent neural networks suitable for 
learning both temporal and spatial patterns [49]. This kind of network is very 
useful for real-time applications such as biomedical signal recording and 
analysis.  
 
 
3.3. Elman and Jordan Neural Networks 
Both the Elman and Jordan neural networks represent special cases of the 
general class of RNN architecture, comprising input, hidden, and output layers of 
units, with the addition of weighted delay lines, known as context units, 
connected to either the hidden or output layer. The context units are a key 
feature of these networks, copying previous outputs back to the layer units for 
use with current processing. The architectures for the Elman and Jordan 
networks are illustrated in Figures 1 and 2, respectively, with equations listed in 
Tables 1 and 2. As can be seen, both networks are equipped with context units, 
with the sole difference that the Jordan network has connections at the output 
layer as opposed to the hidden layer. In addition to these network types, we also 
introduce for experimentation a hybrid network, where the context units from both 
the Elman and Jordan network are simultaneously incorporated into a single 
model, using the connections of both. The hybrid architecture is demonstrated in 
Figure 3, with equations for the network computation listed in Table 3. 
Similarly to other types of neural network, for the architectures considered in this 
study, the units at the input do not perform computation and serve only to 
distribute the input values to subsequent layers. Additionally, Elman and Jordan 
networks represent universal approximators, capable of estimating any numerical 
function within an arbitrary degree of accuracy, given a sufficient number of units 
within the hidden layer. In accord with the class of RNN models, Elman and 
Jordan networks are also theoretically capable of universal computation (Turing 
completeness) [50-52], since the current links provide additional operational 
capabilities beyond the reach of feedforward neural networks, for example 
looping provision. Consequently, the hybrid Elman-Jordan network is also a 
universal approximator, due to spanning the set of Turing primitive operations. 
 
 
 
 
Table 1. Elman Network computations 
Entity Equation 
tansign activation function �ሺ�ሻ = ʹ/ሺͳ + �−ଶ௡ሻ − ͳ 
current input vector ࢞� 
hidden state at previous time ��−ଵ 
hidden state at current time ��  =  �ሺ࢟�−ଵ + �ℎ௫࢞� + �ℎሻ 
output vector ࢟�  =  �ሺ�௬ℎ��ሻ 
 
 
Figure 1. Elman Neural Network 
Table 2.  Jordan Network computations 
Entity Equation 
tansign activation function �ሺ�ሻ = ʹ/ሺͳ + �−ଶ௡ሻ − ͳ 
current input vector ࢞� 
output state at previous time ࢟�−ଵ 
hidden state at current time ��  =  �ሺ�ℎ௫࢞� + �ℎሻ 
output vector ࢟�  =  �ሺ࢟�−ଵ +  �௬ℎ��ሻ 
The Jordan network can be principally defined in terms of the five equations 
formally described in Table 2. The network is composed of computational units, 
each of which transforms presented inputs according to an activation function, in 
this case the tansig function. Data flows into the network in the form of the 
current input vector, where it is mapped to an output vector according to both the 
connection weights between computational units and the dynamical influence of 
previous inputs.   
 
Figure 2. Jordan Neural Network 
Table 3. Hybrid Network computations 
Entity Equation 
tansign activation function �ሺ�ሻ = ʹ/ሺͳ + �−ଶ௡ሻ − ͳ 
current input vector ࢞�  
hidden state at previous time ��−ଵ 
output state at previous time ࢟�−ଵ 
hidden state at current time ��  =  �ሺ��−ଵ + ࢟�−ଵ + �ℎ௫࢞� + �ℎሻ 
output vector ࢟�  =  �ሺ �௬ℎ��ሻ 
The Elman network can be principally defined in terms of the six equations 
formally described in Table 3. The network is composed of computational units, 
each of which maps presented inputs according to an activation function, in this 
case the tansig function. Data flows into the network in the form of the current 
input vector, where it is mapped to an output vector according to both the 
connection weights between computational units and the dynamical influence of 
previous inputs and outputs.    
 
Figure 3. Hybrid Neural Network 
4.  Methodology 
Most studies in the field of machine learning algorithms have been constructed to 
predict the severe crises of sickle cell disease, in contrast to using advanced 
predication to determine accurate amounts of a drug called 
hydroxyurea/hydroxycarbamide, which is used to modify the disease phenotype 
[15, 53, 54]. Currently there is no standardisation for disease modifying therapy 
management. Using the proposed computerised comprehensive management 
system, the aim is to produce an optimised and reproducible standard of care in 
different clinical settings across the UK, and indeed internationally. The main 
backbone of this research is to use recent advances in neural network models, in 
order to assist healthcare professionals in offering accurate amounts of 
medication for each individual patient according to their condition. In this case, 
and due to the pattern of the SCD dataset, we attempt to propose classification 
of the patient’s data set records at an earlier stage, according to how much of a 
dose the patient will need to take. This can potentially lower costs, avoiding 
unnecessary admission to hospitals or special institutions, improving patient 
welfare and mitigate patient illness before it gets worse over time, particularly 
with elderly people, and unnecessary interventions. 
In this research, we attempt to tackle the problem of a certain symptom that 
affects SCD patients depending on medical measurements with a predictive 
classification perspective. Machine learning approaches can be used to build 
strong classifiers to utilise training and testing datasets, involving past observed 
cases that have been collected from Liverpool Centre for Sickle Cell Disease in 
the UK over the last five years. In this case, we examine the performance of 
current machine learning algorithms such as neural networks for constructing 
predictive models. 
4.1. Data Collection 
The dataset utilised in our experiments for SCD patients was commissioned 
specifically for the purposes of this study and was collected within a five-year 
period from the Alder Hey Children’s hospital based in Liverpool, UK. Each 
sample comprises 13 attributes deemed vital factors for predicting the SCD trait 
as illustrated in Table 4. Furthermore, there are two features that should be 
considered when analysing blood test, which are gender and age [55]. These 
features have significant effects on the blood test. In order to work with a large 
amount of data, a local hospital has supported this research with a number of 
patient records. The resulting dataset comprises 1168 sample points, with a 
single target variable describing the hydroxyurea/hydroxycarbamide medication 
dosage in milligrams. To facilitate our classification study, the target dosage was 
discretised into 3 bins, denoted classes 1 through 3, formed through dividing the 
output range (in Milligrams)  into membership intervals of equal size: Class 1: 
[300 ≤ Y < 533mg], Class 2: [533 ≤ Y < 766mg], Class 3: [766 ≤ Y ≤ 1000mg]. 
Such a division was conducted in order to provide adequate class representation 
over the data sample, while preserving some level of precision for the dosage 
outcome. The decision represents a trade-off, since our data sample was limited 
to one hundred examples, thereby excluding the possibility of a reasonable 
division for more than three classes.   
Table 4.  Characteristics of SCD Datasets 
No Types of Attributes 
1 Weight 
2 Haemoglobin(Hb) 
3 Mean Corpuscular Volume (MCV) 
4 Platelets(PLTS) 
5 Neutrophils (white blood cell NEUT) 
6 Reticulocyte Count (RETIC A) 
7 Reticulocyte Count (RETIC %) 
8 Alanine aminotransferase (ALT) 
9 Body Bio Blood (BIO) 
10 Hb F 
11 Bilirubin (BILI) 
12 Lactate dehydrogenase (LDH) 
13 Aspartate Aminotransferase (AST) 
 
4.2. Experimental Setup 
In this section, we cover the design of the test environment used in our 
experiments and the models tested, the configuration of each model, and finally 
the performance evaluation metrics used to measure the outcomes of the 
machine learning models for SCD data set.  
In order to comprehensively test the capability of the models in our study, we 
applied several competing models to the same classification task, contrasted 
with a random oracle model (ROM) [56] to serve as a baseline indicator. 
Moreover, we introduced a linear model to examine the differential in 
performance present between this weak classifier and the non-linear classifiers, 
such as neural networks. The combination of strong, weak, and random control 
baselines provides an empirical frame of reference through which to gauge the 
relative performance of the RNNs. We note also that such a set of reference 
controls is useful to justify the integrity of the results obtained, since it can be 
shown that such performance cannot be reached through either the linear model 
or by random guessing. 
Holdout method is used in these experiments for assessing how the outcomes of 
a statistical analysis could generalise to an independent datasets. The proportion 
of the dataset is divided into three parts training, validation, and testing phases. 
This study used the holdout method of data partitioning to find an average 
percentage of the correct classifications. The training set receives 70 % of the 
available data, the validation set 10%, while the testing set is allocated the 
remaining 20%. The division of data between separate training and testing sets 
ensures that the generalisation error of the models can be assessed, 
demonstrating the ability of classifiers to operate on unseen data.  
The models under study are composed of three types of RNNs: the Elman 
Neural Network Classifier (ENNC), the Jordan Neural Network Classifier (JNNC), 
and hybrid RNN, where both the Elman and Jordan connections are combined 
within a single model (EJNNC). Other model set is composed of a multi-layer 
perceptron, trained using the Levenberg-Marquardt learning algorithm (LEVNN), 
random forest classifier (RFC), and support vector machine classifier (SVM). 
These models are considered strong non-linear classifiers and are suitable to act 
as comparators of high performance. The linear model we used comprises a 
single layer neural network with a linear transformation function at each class 
output unit. Finally, we used random oracle model (ROM) to establish random 
case performance through the assignment of random responses for each class. 
To obtain performance estimates for the respective models, we ran each 
simulation 50 times and calculates the mean of the responses. The full set of 
models used in the experiments are described in Table 5. 
 
 
 
 
  
 
 
 
 
 
Table 5. Classification Models 
Model 
Designation Description Architecture Training Algorithm 
Parameters Role 
ENN Elman Neural Network 
Units: 13-30-3, 
tansig activations. 
Context Units: One 
context unit for each 
hidden unit. 
Gradient descent with 
momentum and 
adaptive learning rate 
backpropagation 
Initial Learning Rate: 0.01 
LR Increase Coefficient: 
1.05 
LR Decrease Coefficient: 
0.7 
Momentum Constant: 0.9 
Test model 
JNN Jordan Neural Network 
Units: 13-30-3, 
tansig activations. 
Context Units: One 
context unit for each 
output unit. 
Gradient descent with 
momentum and 
adaptive learning rate 
backpropagation 
Initial Learning Rate: 0.01 
LR Increase Coefficient: 
1.05 
LR Decrease Coefficient: 
0.7 
Momentum Constant: 0.9 
Test model 
EJNN 
Elman-Jordan 
Hybrid Neural 
Network 
Units: 13-30-3, 
tansig activations 
Gradient descent with 
momentum and 
adaptive learning rate 
backpropagation 
Initial Learning Rate: 0.01 
LR Increase Coefficient: 
1.05 
LR Decrease Coefficient: 
0.7 
Momentum Constant: 0.9 
Test model 
LEVNN 
Multilayer 
Perceptron, 
Trained using 
the Levenberg-
Marquardt 
algorithm 
Units: 13-2-3, tansig 
activations Levenberg-Marquardt 
Initialisation: 
Nguyen Widrow Adaptive 
learning rate settings: 
initial value: 0.001 
coefficient for increasing 
LR: 10 
coefficient for decreasing 
LR: 0.1 
maximum learning rate: 
1e10 
Non-linear 
Comparison 
Model 
RFC 
Random 
Forest, 
Decision Tree 
Ensemble 
Classifier 
13 inputs, 200 
Trees, 3 outputs 
Random feature 
bagging 
Number of decision trees to 
be generated 200; 
Size of feature subsets: 1 
Non-linear 
Comparison 
Model 
SVM Support Vector Machine 13 inputs, 3 outputs 
Quadratic 
Optimisation 
Kernel: Distance matrix 
Optimisation: regularised 
Non-linear 
Comparison 
Model 
LNN 
Linear 
Combiner 
Network 
Units: 13-3, linear 
activations Widrow-Hoff 
Learning rate: 0.01 Linear 
Comparison 
Model 
ROM Random Oracle Model 
Pseudorandom 
number generator N/A 
N/A Random 
Guessing 
Baseline 
 
Table 6. Performance Metric Calculations 
Metric Name Calculation 
Sensitivity TP/(TP+FN) 
Specificity TN/(TN+FP) 
Precision TP/(TP+FP) 
F1 Score 2 * (Precision*Recall)/(Precision+Recall) 
Youden's J statistic (J Score) Sensitivity + Specificity − 1 
Accuracy (TP+TN)/(TP+FN+TN+FP) 
Area Under ROC Curve 
(AUC) 0 <= Area under the ROC Curve <= 1 
 
Our model evaluation framework consists of both in-sample (training) and out-of-
sample (testing) diagnostics, comprising sensitivity, specificity, precision, the F1 
score, Youden’s J statistic, and overall classification accuracy calculated as 
shown in Table 6.  Additionally, the classifiers are characterised using ROC plots 
and the area under the curve (AUC), where the classification ability across all 
operating points is ascertained. 
5. Results Evaluation 
The results from our experiments are listed in Tables 7 and 8, showing outcomes 
for training and testing of the classifiers, respectively. We also provide further 
performance visualisations through the use of ROC plots (Figures 4 and 5) and 
the use of AUC plots as illustrated in Figures 6 and 7. The AUC bar graphs 
provide a visual comparison of the area under the ROC curve across the models 
tested.  
The results obtained from the experiments show that the LEVNN and RFC 
classifiers outperformed all other classifiers, including the RNNs, by a significant 
margin. Both classifiers achieve an ideal fit over the trainings set for all operating 
points, as can be illustrated in Table 7 and the ROC and AUC plots shown in 
Figures 4 and 6, respectively. Moreover, the performance obtained during the 
training of these two classifiers is shown to provide excellent generalisation to 
the test set, with AUCs ranging between 0.986 to 0.996. The strong 
generalisation of these two classifiers indicates that there exists rich information 
content embedded within our selected data source, showing a high upper bound 
on classification performance. We conducted further experiments using SVM 
classifier, showing that this class of model is significantly less capable for 
classifying our dataset.  
Further experiments show that the chosen dataset exhibits significant non-linear 
relationships, presenting a challenge for RNN test models. Of the RNN classifiers 
under study, the Jordan network outperformed the Elman and Elman-Jordan 
hybrid, demonstrating capability both for fitting the training data and also in 
generalising to unseen examples. The AUCs obtained for the Jordan model 
during training are 0.982, 0.93, and 0.97 for classes 1 to 3 respectively, in 
comparison to 0.969, 0.913, and 0.962 over the test sample. Subsequently, a 
single operating point was selected to illustrate a final classification decision; it 
was found that the performance at the chosen rejection threshold varied between 
the training and testing sets for Class 2, as reflected earlier in the AUC values. 
Classes 1 and 3 were found to show reasonably consistent performance 
representation between the train and test sets for this model. It is possible that 
the reasonable performance obtained for the JNN architecture, in contrast with 
the poor performance of the other RNN types, could point to a detrimental effect 
caused by presence of feedbacks from the hidden layer outputs in the 
classification setting. The final layer output feedbacks present in the JNN model, 
appear not to negatively impact learning. 
The Elman and Elman-Jordan RNNs are found to perform similarly to one 
another, with both ranking below the JNN for both the training and testing sets. 
The AUC values for both models ranged between 0.738, and 1 in respect to the 
training set, and 0.685 to 0.906 for the testing procedure. Consistent with the 
results obtained from the JNN, it was found that the outcomes for Class 2 show 
the largest differential between the training and testing sets. On further 
examination of the results from the ENN and EJNN, it was found that despite the 
appearance of reasonable AUC values during training, the networks had 
converged to a particularly narrow output range, suggesting that the training 
process is unable to achieve clear correspondence with the classification targets, 
arriving instead at marginal responses. Further confirmation is reflected in the 
sensitivities and specificities obtained for these two models, with values seen to 
fluctuate between opposite extremes. Such a situation stands in contrasted with 
the JNN model, for which a reasonable range of output values is achieved during 
both train and test phases. It is noted that for both the ENN and EJNN, the 
operation of the hidden layer is altered using recurrent links, whereas the JNN 
hidden layer is altered via feedback from the output layer. 
It is shown that the model does not generalise well from training to testing, 
producing reasonable AUCs for in-sample fitting, while yielding test set AUCs 
little better than the LNN baseline. The test AUCs for this model ranged between 
0.49 and 0.46. As expected, the LNN was unable to learn the non-linear 
components in the data and so produces weak classification results against 
which the other classifiers can be contrasted. The ROM is seen to follow the 
diagonal of the ROC plots for all classes (see Figure 4 and 5), illustrating by 
contrast the significance of the results from the other trained classifiers. 
Table 7. Comparison Table for Classifiers (Training) 
Models Class Sensitivity Specificity Precision F1 J Accuracy AUC 
ROM 
Class 1 0.202 0.816 0.516 0.291 0.0183 0.514 0.519 
Class 2 0.227 0.79 0.399 0.289 0.017 0.576 0.5 
Class 3 0.181 0.784 0.109 0.136 -0.0349 0.707 0.478 
ENNC 
Class 1 0.998 0.012 0.494 0.661 0.00949 0.497 0.95 
Class 2 0.617 0.796 0.65 0.633 0.413 0.728 0.815 
Class 3 0 1 0 0 0 0.872 0.738 
JNNC 
Class 1 0.983 0.797 0.824 0.896 0.779 0.888 0.982 
Class 2 0.971 0.731 0.689 0.806 0.703 0.823 0.93 
Class 3 0.695 0.994 0.948 0.802 0.69 0.956 0.97 
EJNNC 
Class 1 0.998 0.00478 0.493 0.66 0.00232 0.493 0.956 
Class 2 0.92 0.669 0.63 0.748 0.589 0.764 0.823 
Class 3 0 1 0 0 0 0.872 0.938 
LEVNN 
Class 1 1 1 1 1 1 1 1 
Class 2 1 1 1 1 1 1 1 
Class 3 0.99 1 1 0.995 0.99 0.999 1 
RFC 
Class 1 1 1 1 1 1 1 1 
Class 2 1 1 1 1 1 1 1 
Class 3 1 1 1 1 1 1 1 
SVM 
Class 1 0.284 0.993 0.975 0.44 0.277 0.644 0.976 
Class 2 0.00319 1 1 0.00637 0.00319 0.621 0.729 
Class 3 0 1 0 0 0 0.872 0.969 
LNN 
Class 1 0.783 0.627 0.67 0.722 0.41 0.704 0.77 
Class 2 0.0575 0.929 0.333 0.0981 -0.0131 0.598 0.635 
Class 3 0.214 0.962 0.6 0.316 0.177 0.806 0.792 
 
Table 8. Comparison Table for Classifiers (Testing) 
MODELS CLASS SENSITIVITY SPECIFICITY PRECISION F1 J ACCURACY AUC 
ROM 
Class 1 0.191 0.833 0.524 0.28 0.0246 0.519 0.49 
Class 2 0.185 0.741 0.315 0.233 -0.074 0.523 0.464 
Class 3 0.321 0.768 0.158 0.212 0.0895 0.715 0.46 
ENNC 
Class 1 1 0 0.489 0.657 0 0.489 0.906 
Class 2 0.543 0.769 0.602 0.571 0.313 0.681 0.778 
Class 3 0 1 0 0 0 0.881 0.685 
JNNC 
Class 1 0.983 0.758 0.796 0.879 0.741 0.868 0.969 
Class 2 0.913 0.706 0.667 0.771 0.619 0.787 0.913 
Class 3 0.893 0.99 0.926 0.909 0.883 0.979 0.962 
EJNNC 
Class 1 1 0 0.489 0.657 0 0.489 0.917 
Class 2 0.826 0.643 0.598 0.694 0.469 0.715 0.777 
Class 3 0 1 0 0 0 0.881 0.868 
LEVNN 
Class 1 1 0.983 0.983 0.991 0.983 0.991 0.989 
Class 2 0.978 1 1 0.989 0.978 0.991 0.991 
Class 3 0.964 0.995 0.964 0.964 0.959 0.991 0.996 
RFC 
Class 1 0.991 0.958 0.958 0.974 0.95 0.974 0.996 
Class 2 0.815 0.993 0.987 0.893 0.808 0.923 0.992 
Class 3 0.786 0.99 0.917 0.846 0.776 0.966 0.986 
SVM 
Class 1 0.217 0.992 0.962 0.355 0.209 0.613 0.97 
Class 2 0 1 0 0 0 0.609 0.739 
Class 3 0 1 0 0 0 0.881 0.964 
LNN 
Class 1 0.687 0.658 0.658 0.672 0.345 0.672 0.742 
Class 2 0.0543 0.944 0.385 0.0952 -0.0016 0.596 0.654 
Class 3 0.0357 0.894 0.0435 0.0392 -0.0706 0.791 0.641 
 
 
Figure 4.  ROC curve (Train) For classifiers 
 Figure 5. ROC curve (Testing) For classifiers 
 
Figure 6. Train AUC per model 
The plots show in Figures 6 and 7 show the area under the ROC curve (AUC) for 
each class over each model within our experiment. Figure 6 shows the results 
obtained for the training set and Figure 7 the test set, respectively. The AUC 
value is a scalar summary used to characterise the global capability of a given 
classifier under study. In our plots, the X axis shows the models and classes, 
while the Y axis shows the AUC that corresponds to each of the model entries 
listed over the X axis. An AUC of 1 represents an ideal classifier, while an AUC 
of 0.5 represents random performance. Each of the bars plotted is associated 
with a corresponding curve in either of Figures 4 and 5, which represent the 
accompanying ROC curves for the training and testing sets. The purpose of the 
plot is to emphasise the AUC values in graphical form, such that a visual 
comparison can be drawn. 
 
Figure 7.  Test AUC per model 
Overall, the body of results that we obtained highlight the potential of medical 
data for the classification of SCD dosage ranges. It is clear that the choice of 
model is crucial in obtaining a satisfactory result, as is evident in the variation of 
the performance between the models used in our experiment. The LEVNN and 
RFC classifiers responded successfully to the SCD data and are therefore of 
potential use in the medical field. 
6. Conclusion and Future works  
In this study, we have conducted an empirical investigation into the use of 
various types of machine learning models for the classification of SCD effective 
dosage levels. This paper has introduced various types of recurrent neural 
network for the purpose of analysing medical time series obtained from SCD 
patients in contrast with traditional medical solutions. Previous studies have 
demonstrated that Machine learning models exhibit considerable effectiveness 
for the pre-processing of medical time-series data signals as a precursor to the 
classification of medical data. Our study sought to investigate the effectiveness 
of machine learning approach including ANNs when posed in the direct 
classification setting for classification of SCD effective dosage levels. It was 
found through empirical investigation, involving the use of patient sample data 
and comparator models such as SVM and RFC, that RNNs, although capable of 
providing some degree of fitting and generalisation, are suboptimal in the 
classification setting within our experiment. We consider for future work the use 
of global optimisation algorithms such as genetic optimisation to explore more 
comprehensively the space of possible recurrent network architectures. We note 
that the current study has addressed only a limited set of architectures, which 
may not expose the full potential of the RNNs within the classification setting; we 
suggest therefore that an algorithmic model search may be used to expand the 
scope and scale of this study. 
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